Blog

For many people, the coronavirus pandemic has changed their nutrition and exercise habits. One app helping people track their food and lose weight is called Lifesum. The company has scaled rapidly

Pfizer (NYSE: PFE) and its German partner BioNTech (NASDAQ: BNTX) reported incredible efficacy data from a phase 3 trial for their mRNA coronavirus vaccine candidate. This news, paired with the

The early bird catches the worm, but what does the early claimer of Social Security benefits catch? Well, in many cases, they collect more money, in total, from Social Security than do those who

If you've ever tucked into a packet of Frito-Lay potato chips while watching a movie at home or refreshed yourself with a can of Gatorade after a gym workout, you would be enjoying one of the myriad

Of the various expenses you'll face during retirement, healthcare will likely be a big one. It's important to understand what your Medicare costs will look like so you can accurately work them into

Market leaders sometimes rest on their laurels and miss the next wave of innovation in their industries. The idea was captured in Clayton Christensen's book, The Innovator's Dilemma, and was applied

My family's portfolios are filled with internet retailers that are skyrocketing, Software-as-a-Service stocks that are soaring, and one vaccine biotech that has jumped 2,000%. It's my first year

Pfizer (NYSE: PFE) and its German partner BioNTech (NASDAQ: BNTX) reported incredible efficacy data from a phase 3 trial for their mRNA coronavirus vaccine candidate. This news, paired with the

Retiring as soon as possible may seem like an attractive prospect if you're eager to spend your days on the golf course, spoiling your grandkids, or traveling the world. But while there are some

Pfizer (NYSE: PFE) and its German partner BioNTech (NASDAQ: BNTX) reported incredible efficacy data from a phase 3 trial for their mRNA coronavirus vaccine candidate. This news, paired with the

After another quarter of selling off bank stocks, Berkshire Hathaway (NYSE: BRK.A) (NYSE: BRK.B) and its legendary chairman and CEO, Warren Buffett, are clearly getting more selective in the sector

Many investors buy dividend stocks for one reason: They want a reliable income stream.

Some stocks generate larger income streams, while others provide more reliability. If you're looking for both

Every month, Social Security doles out payments to nearly 65 million Americans, over 46 million of whom are retired workers. Without this guaranteed payout, more than 15 million retirees would be

2020 has been a brutally volatile year for stocks. While the market is on track to finish solidly higher than it started on an incredible bounce back from the lows of late March, plenty of

This has been a trying year for Wall Street and the investment community. Though volatility is always present in the stock market, the swings we've witnessed this year are far beyond historical

Saving for education can help minimize future student loan debt. Money you save now can grow and have huge benefits for your children down the road.

In this video from the Motley Fool Live Financial

Moderna (NASDAQ: MRNA) recently announced an impressive efficacy of 94.5% from a late-stage study of coronavirus vaccine candidate mRNA-1273. The biotech stock jumped on the good news, but is it

2020 has seen a truckload of dividend cuts, suspended payouts, and unhappy shareholders, especially from high-profile companies like Disney and Ford. However, there are plenty of lesser-known

In this episode of MarketFoolery, Chris Hill chats with Motley Fool analyst Ron Gross about the latest headlines and earning reports from Wall Street. They've got some updates on the coronavirus

Pfizer (NYSE: PFE) and BioNTech (NASDAQ: BNTX) were the first drugmakers to announce interim efficacy results from a late-stage study of their coronavirus vaccine candidate. Moderna (NASDAQ: MRNA)

Fears about the future of Social Security have been around for decades, perpetuated in part by a general lack of understanding about how the program works. I'll be honest: Social Security isn't in a

In this video from Motley Fool Live recorded on Nov. 12, executives from Sorrento Therapeutics (NASDAQ: SRNE) talk about the company's second-generation therapeutic antibody. An investigational new

This year has been pretty busy for IPOs despite the coronavirus pandemic. Online gaming platform Roblox has now officially filed its S-1 Registration Statement with the SEC after submitting a

Stocks ticked lower last week, as both the Dow Jones Industrial Average and the S&P 500 shed less than 1%. This left both indexes near their all-time highs and in positive territory so far in 2020.

On Wednesday, Target (NYSE: TGT) posted third-quarter results that featured phenomenal sales growth and a massive surge in earnings, obliterating analysts' expectations. With the retailer on track